Answer
There is no information on whether inhaled zanamivir (Relenza) passes into human breast milk; despite low systemic exposure, infant risk cannot be excluded, so breastfeeding or therapy must be stopped or avoided after weighing their respective benefits.
Sources for this answer
- Relenza 5mg/dose inhalation powder.GlaxoSmithKline UK · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 26Document updated
Sources checked